186 related articles for article (PubMed ID: 22840328)
1. Adoptive transfer of naïve dendritic cells in resolving post-sepsis long-term immunosuppression.
Laudanski K
Med Hypotheses; 2012 Oct; 79(4):478-80. PubMed ID: 22840328
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes.
Wen H; Schaller MA; Dou Y; Hogaboam CM; Kunkel SL
J Leukoc Biol; 2008 Mar; 83(3):439-46. PubMed ID: 17991763
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications.
Wu DD; Li T; Ji XY
J Immunol Res; 2017; 2017():3591248. PubMed ID: 29075648
[TBL] [Abstract][Full Text] [Related]
4. The chronic consequences of severe sepsis.
Benjamim CF; Hogaboam CM; Kunkel SL
J Leukoc Biol; 2004 Mar; 75(3):408-12. PubMed ID: 14557384
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia.
Bouras M; Asehnoune K; Roquilly A
Front Immunol; 2018; 9():2590. PubMed ID: 30483258
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis.
Wang G; Li X; Zhang L; Elgaili Abdalla A; Teng T; Li Y
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32197507
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.
Flohé SB; Agrawal H; Schmitz D; Gertz M; Flohé S; Schade FU
J Leukoc Biol; 2006 Mar; 79(3):473-81. PubMed ID: 16365154
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells in transplantation and immune-based therapies.
Young JW; Merad M; Hart DN
Biol Blood Marrow Transplant; 2007 Jan; 13(1 Suppl 1):23-32. PubMed ID: 17222766
[TBL] [Abstract][Full Text] [Related]
12. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity.
Rossi M; Young JW
J Immunol; 2005 Aug; 175(3):1373-81. PubMed ID: 16034072
[TBL] [Abstract][Full Text] [Related]
13. Modulation of dendritic cell differentiation in the bone marrow mediates sustained immunosuppression after polymicrobial sepsis.
Pastille E; Didovic S; Brauckmann D; Rani M; Agrawal H; Schade FU; Zhang Y; Flohé SB
J Immunol; 2011 Jan; 186(2):977-86. PubMed ID: 21160046
[TBL] [Abstract][Full Text] [Related]
14. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection.
Celluzzi CM; Falo LD
J Immunol; 1998 Apr; 160(7):3081-5. PubMed ID: 9531260
[TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
16. [Dendritic cells in sepsis: an approach to post-infectious immunosuppression].
Sirgo G; Claramonte R; Chánovas M; Esteban F; Forcadell I; Luna J; Masdeu G; Ramón Vázquez J; Artigas A
Med Intensiva; 2010 Nov; 34(8):559-66. PubMed ID: 20034705
[TBL] [Abstract][Full Text] [Related]
17. Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation.
Perruccio K; Bozza S; Montagnoli C; Bellocchio S; Aversa F; Martelli M; Bistoni F; Velardi A; Romani L
Blood Cells Mol Dis; 2004; 33(3):248-55. PubMed ID: 15528139
[TBL] [Abstract][Full Text] [Related]
18. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
19. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
20. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
Land WG
Transplant Rev (Orlando); 2012 Apr; 26(2):88-102. PubMed ID: 22000661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
